Delivery Order SPE2DB22D3501-SPE2DB25FXN26
Award Date 9/25/25
Potential Completion Date 9/26/25
Potential Value $9.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,337.06 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count) on June 2, 2025, with completion scheduled for June 3, 2025. This delivery order was issued under a firm fixed-price contract structure with no set-aside designation, indicating competitive award. The product will be performed from AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,915.76 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count units) under a firm fixed-price contract. The award was made on August 27, 2025, with an ultimate completion date of August 28, 2025, with performance to take place at the vendor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a single...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) with a ceiling value of $10,879.54. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a $9,109.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Candesartan Cilexetil 16 mg tablets in a quantity of 90 units. The contract is unclassified with no set-aside designation and carries an ultimate completion date of September 26, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) with a ceiling value of $1,175.41. This firm fixed-price delivery order, with an ultimate completion date of August 22, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count) with a ceiling value of $102,998.84. This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,485.26 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90-count bottles) under a firm fixed-price contract. This competitively awarded delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a single transaction within DLA's pharmaceutical supply chain operations. The contract involves no set-aside designation and is being performed at...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,950.76 for Candesartan Cilexetil 8 mg tablets (90-count) on September 2, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count) under a firm fixed-price contract valued at $2,048.27. The award was made on August 21, 2025, with an ultimate completion date of August 22, 2025. No set-aside designation was used for this procurement, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count) with a ceiling value of $1,509.76. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply...